Ivonescimab (AK112)
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Ivonescimab (AK112), covering 2025-01-09 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study on Noninvasive Evaluation of Ivonescimab Antibody Distribution and Expression in Esophageal Cancer Patients by 89Zr-AK112 PET Imaging